Carlos Cruchaga
Affiliations: | Washington University School of Medicine, St. Louis, MO, United States |
Area:
Alzheimer's, genetics, genomics, quantitative traits, WES, WGS, proteomicsGoogle:
"Carlos Cruchaga"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Juan Jose Martinez | grad student | Universidad de Navarra | |
| Alison M. Goate | post-doc | ||
| Pau Pastor | post-doc |
Children
Sign in to add trainee| Umber Dube | grad student | Washington University School of Medicine | |
| Maria Victoria Fernandez | grad student | Washington University School of Medicine | |
| Laura Ibanez | grad student | Washington University School of Medicine | |
| Peter Jin | grad student | Washington University School of Medicine | |
| Chengran Yang | grad student | Washington University School of Medicine | |
| Yuetiva Deming | grad student | 2011-2017 | Washington University School of Medicine |
| Oscar Harari | grad student | 2013-2019 | Washington University School of Medicine |
| Zeran Li | grad student | 2015-2019 | Washington University School of Medicine |
| Bruno A. Benitez | post-doc | Washington University School of Medicine | |
| Jenny Lord | post-doc | Wellcome Sanger Institute | |
| Yuetiva Deming | post-doc | 2017-2018 | Washington University School of Medicine in St. Louis |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Doering S, McCullough A, Gordon BA, et al. (2024) Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging. Ebiomedicine. 103: 105080 |
| Meeker KL, Luckett PH, Barthélemy NR, et al. (2024) Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease. Brain Communications. 6: fcae081 |
| Cruchaga C, Ali M, Shen Y, et al. (2024) Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease. Research Square |
| Joseph-Mathurin N, Feldman RL, Lu R, et al. (2024) Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Wang Q, Schindler SE, Chen G, et al. (2024) Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging. Neurology. 102: e208013 |
| Shen Y, Ali M, Timsina J, et al. (2024) Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways. Medrxiv : the Preprint Server For Health Sciences |
| Vance JM, Farrer LA, Huang Y, et al. (2024) Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease. Annals of Neurology |
| Wang L, Nykänen NP, Western D, et al. (2024) Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease. Molecular Neurodegeneration. 19: 1 |
| Gunasekaran TI, Reyes-Dumeyer D, Faber KM, et al. (2023) Identification of Rare Damaging Missense and Loss of Function Variants in GWAS Loci Using Genome Sequencing Data from Two Cohorts of Familial Late-Onset Alzheimer's Disease. Medrxiv : the Preprint Server For Health Sciences |
| Millar PR, Gordon BA, Wisch JK, et al. (2023) Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease. Molecular Neurodegeneration. 18: 98 |